Australia markets open in 7 hours 17 minutes

Profound Medical Corp. (PRN.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
11.19-0.32 (-2.78%)
At close: 03:35PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 273.36M
Enterprise value 227.20M
Trailing P/E 74.00
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)24.83
Price/book (mrq)4.38
Enterprise value/revenue 23.05
Enterprise value/EBITDA -7.93

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-36.60%
S&P500 52-week change 326.49%
52-week high 320.44
52-week low 39.55
50-day moving average 310.94
200-day moving average 311.91

Share statistics

Avg vol (3-month) 34.47k
Avg vol (10-day) 35.13k
Shares outstanding 524.43M
Implied shares outstanding 624.43M
Float 821.68M
% held by insiders 18.71%
% held by institutions 138.94%
Shares short (30 Apr 2024) 488.51k
Short ratio (30 Apr 2024) 425.15
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.36%
Shares short (prior month 28 Mar 2024) 482.29k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 316 Oct 2019
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 316 Oct 2019

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-391.73%

Management effectiveness

Return on assets (ttm)-30.83%
Return on equity (ttm)-59.26%

Income statement

Revenue (ttm)7.25M
Revenue per share (ttm)0.33
Quarterly revenue growth (yoy)2.70%
Gross profit (ttm)N/A
EBITDA -28.49M
Net income avi to common (ttm)-28.03M
Diluted EPS (ttm)-1.75
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)41.18M
Total cash per share (mrq)1.73
Total debt (mrq)7.24M
Total debt/equity (mrq)15.78%
Current ratio (mrq)5.41
Book value per share (mrq)1.92

Cash flow statement

Operating cash flow (ttm)-21.57M
Levered free cash flow (ttm)-12.64M